Raquel Martinez de Mena

Raquel Martinez de Mena

Auto-generated profile, based on publicly available information

Raquel Martinez de Mena

Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
MKMonique H. A. Kester
Monique H. A. Kester
RMRaquel Martinez de Mena
Raquel Martinez de Mena
MOMaria Jesus Obregon
Maria Jesus Obregon
DMDanijela Marinkovic
Danijela Marinkovic
AHAllan Howatson
Allan Howatson
GEGabriella Morreale de Escobar
Gabriella Morreale de Escobar
Thyroid hormones are required for human brain development, but data on local regulation are limited. We describe the ontogenic changes in T(4), T(3), and rT(3) and in the activities of the types I, II, and III iodothyronine deiodinases (D1, D2, and D3) in different brain regions in normal fetuses (13-20 wk postmenstrual age) and premature infants (24-42 wk postmenstrual age). D1 activity was undetectable. The developmental changes in the concentrations of the iodothyronines and D2 and D3 activities showed spatial and temporal specificity but with divergence in the cerebral cortex and cerebellum. T(3) increased in the cortex between 13 and 20 wk to levels higher than adults, unexpected given the low circulating T(3). Considerable D2 activity was found in the cortex, which correlated positively with T(4) (r = 0.65). Cortex D3 activity was very low, as was D3 activity in germinal eminence and choroid plexus. In contrast, cerebellar T(3) was very low and increased only after midgestation. Cerebellum D3 activities were the highest (64 fmol/min.mg) of the regions studied, decreasing after midgestation. Other regions with high D3 activities (midbrain, basal ganglia, brain stem, spinal cord, hippocampus) also had low T(3) until D3 started decreasing after midgestation. D3 was correlated with T(3) (r = -0.682) and rT(3)/T(3) (r = 0.812) and rT(3)/T(4) (r = 0.889). Our data support the hypothesis that T(3) is required by the human cerebral cortex before midgestation, when mother is the only source of T(4). D2 and D3 play important roles in the local bioavailability of T(3). T(3) is produced from T(4) by D2, and D3 protects brain regions from excessive T(3) until differentiation is required.

1 March 2006 in Molecular and Cellular Biology
Verified
Journal Article
Closed access
PDF file
IBIvan del Barco Barrantes
Ivan del Barco Barrantes
AMAna Montero-Pedrazuela
Ana Montero-Pedrazuela
AGAna Guadaño-Ferraz
Ana Guadaño-Ferraz
MOMaria-Jesus Obregon
Maria-Jesus Obregon
RMRaquel Martinez de Mena
Raquel Martinez de Mena
CNChristof Niehrs
Christof Niehrs
dickkopf (dkk) genes encode a small family of secreted Wnt antagonists, except for dkk3, which is divergent and whose function is poorly understood. Here, we describe the generation and characterization of dkk3 mutant mice. dkk3-deficient mice are viable and fertile. Phenotypic analysis shows no major alterations in organ morphology, physiology, and most clinical chemistry parameters. Since Dkk3 was proposed to function as thyroid hormone binding protein, we have analyzed deiodinase activities, as well as thyroid hormone levels. Mutant mice are euthyroid, and the data do not support a relationship of dkk3 with thyroid hormone metabolism. Altered phenotypes in dkk3 mutant mice were observed in the frequency of NK cells, immunoglobulin M, hemoglobin, and hematocrit levels, as well as lung ventilation. Furthermore, dkk3-deficient mice display hyperactivity.

18 August 2010 in Endocrinology
Verified
Journal Article
Closed access
RMRaquel Martinez de Mena
Raquel Martinez de Mena
TSThomas S. Scanlan
Thomas S. Scanlan
MOMaria-Jesus Obregon
Maria-Jesus Obregon
Brown adipose tissue (BAT) thermogenesis increases when uncoupling protein-1 (UCP1) is activated adrenergically and requires T3. In humans, UCP1 activation in BAT seems involved in body weight maintenance. BAT type 2 deiodinase (D2) increases in response to adrenergic agents, producing the T3 required for UCP1 expression. T3 actions are mediated by thyroid hormone nuclear T3 receptors (TR), TRα and TRβ. Studies in mice suggest that TRβ is required for UCP1 induction, whereas TRα regulates body temperature and adrenergic sensitivity. In the present study, we compare the effects of T3vs. specific TRβ1 and TRα1 agonists [GC-1 and CO23] on the adrenergic induction of UCP1 and D2 in cultured rat brown adipocytes. T3 and GC-1 produced similar increases on UCP1, whereas CO23 increased UCP1 only at high doses (50 nm). GC-1 at low doses (0.2–10 nm) was less potent than T3, increasing the adrenergic stimulation of D2 activity and mRNA. At higher doses, GC-1 further stimulated whereas T3 inhibited D2 activity but not D2 mRNA, suggesting posttranscriptional effects. CO23 had no effect on D2 activity but increased D2 mRNA. T3, GC-1, or CO23 by themselves did not increase UCP1 or D2 mRNA. High T3 doses shortened D2 half-life and increased D2 turnover via proteasome, whereas GC-1 did not change D2 stability. The α1- and α2-adrenergic D2 responses increased using high T3 doses. In summary, T3 increases the adrenergic stimulation of UCP1 and D2 expression mostly via the TRβ1 isoform, and in brown adipocytes, D2 is protected from degradation by the action of T3 on TRβ1.

1 January 2013 in Endocrinology
Verified
Journal Article
Closed access
RLRosalia Lavado-Autric
Rosalia Lavado-Autric
RCRosa Maria Calvo
Rosa Maria Calvo
RMRaquel Martinez de Mena
Raquel Martinez de Mena
GEGabriella Morreale de Escobar
Gabriella Morreale de Escobar
MOMaria-Jesus Obregon
Maria-Jesus Obregon
Severe iodine deficiency is characterized by goiter, preferential synthesis, and secretion of T3 in thyroids, hypothyroxinemia in plasma and tissues, normal or low plasma T3, and slightly increased plasma TSH. We studied changes in deiodinase activities and mRNA in several tissues of rats maintained on low-iodine diets (LIDs) or LIDs supplemented with iodine (LID+I). T4 and T3 concentrations decreased in plasma, tissues, and thyroids of LID rats, and T4 decreased more than T3 (50%). The highest type 1 iodothyronine deiodinase (D1) activities were found in the thyroid, kidney, and the liver; pituitary, lung, and ovary had lower D1 activities; but the lowest levels were found in the heart and skeletal muscle. D1 activity decreased in all tissues of LID rats (10–40% of LID+I rats), except for ovary and thyroids, which D1 activity increased 2.5-fold. Maximal type 2 iodothyronine deiodinase (D2) activities were found in thyroid, brown adipose tissue, and pituitary, increasing 6.5-fold in thyroids of LID rats and about 20-fold in the whole gland. D2 always increased in response to LID, and maximal increases were found in the cerebral cortex (19-fold), thyroid, brown adipose tissue, and pituitary (6-fold). Lower D2 activities were found in the ovary, heart, and adrenal gland, which increased in LID. Type 3 iodothyronine deiodinase activity was undetectable. Thyroidal Dio1 and Dio2 mRNA increased in the LID rats, and Dio1 decreased in the lung, with no changes in mRNA expression in other tissues. Our data indicate that LID induces changes in deiodinase activities, especially in the thyroid, to counteract the low T4 synthesis and secretion, contributing to maintain the local T3 concentrations in the tissues with D2 activity.

31 July 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
ALAna Victoria Lechuga-Vieco
Ana Victoria Lechuga-Vieco
ALAna Latorre-Pellicer
Ana Latorre-Pellicer
IJIain G. Johnston
Iain G. Johnston
GPGennaro Prota
Gennaro Prota
UGUzi Gileadi
Uzi Gileadi
JEJosé Antonio Enríquez
José Antonio Enríquez
Cells sense the presence of more than one version of mtDNA and select the variant according to its impact on function.

1 February 2005 in Toxicology
Verified
Journal Article
Closed access
LAL. Alvarez
L. Alvarez
SHS. Hernández
S. Hernández
RMR. Martinez-De-Mena
R. Martinez-De-Mena
RKR. Kolliker-Frers
R. Kolliker-Frers
MOM.J. Obregón
M.J. Obregón
DPD.L. Kleiman de Pisarev
D.L. Kleiman de Pisarev